Evid Invest
Who owns EDITWhat EDIT owns — n/a

Who owns Editas Medicine, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of EDIT from SEC Form 13F filings across 219 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 219 institutions disclosed 139.5M shares of Editas Medicine, Inc. worth $356.5M — about 90.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

219

13F holders

$356.5M

value, 2026 filers

90.8%

of shares outstanding (139.5M sh)

34

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of EDIT's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.14.4M$37.0M0.0%9.4%+36.0%
2TCG Crossover Management, LLC11.1M$28.6M0.8%7.2%0.0%
3ADAR1 Capital Management, LLC8.9M$22.8M1.0%5.8%0.0%
4Commodore Capital LP8.9M$22.8M1.8%5.8%0.0%
5RA CAPITAL MANAGEMENT, L.P.8.9M$22.8M0.2%5.8%0.0%
6Paradigm Biocapital Advisors LP7.6M$19.5M0.4%4.9%+35.6%
7STATE STREET CORP7.0M$18.1M0.0%4.6%+221.1%
8VANGUARD CAPITAL MANAGEMENT LLC6.1M$15.6M0.0%4%-1.1%
9VANGUARD PORTFOLIO MANAGEMENT LLC4.7M$12.0M0.0%3%+30.1%
10GEODE CAPITAL MANAGEMENT, LLC3.9M$10.0M0.0%2.5%+51.4%
11Woodline Partners LP3.6M$9.1M0.0%2.3%0.0%
12Vivo Capital, LLC3.6M$9.1M1.0%2.3%0.0%
13Opaleye Management Inc.3.5M$9.0M1.0%2.3%-9.7%
14GOLDMAN SACHS GROUP INC3.2M$8.3M0.0%2.1%+24.1%
15D. E. Shaw & Co., Inc.3.2M$8.2M0.0%2.1%+67.8%
16GordonMD Global Investments LP3.1M$8.0M4.8%2%0.0%
17MARSHALL WACE, LLP3.0M$7.8M0.0%2%+48.5%
18RENAISSANCE TECHNOLOGIES LLC2.5M$6.4M0.0%1.6%+1.2%
19Logos Global Management LP2.2M$5.7M0.3%1.4%0.0%
20Seven Fleet Capital Management LP1.9M$2.9M0.6%1.2%+44.0%
21JPMORGAN CHASE & CO1.9M$4.8M0.0%1.2%+0.2%
22UBS Group AG1.4M$3.7M0.0%0.9%+90.1%
23TWO SIGMA INVESTMENTS, LP1.3M$3.4M0.0%0.9%-1.0%
24RAYMOND JAMES FINANCIAL INC1.3M$3.4M0.0%0.9%-0.1%
25KENNEDY CAPITAL MANAGEMENT LLC1.3M$3.3M0.1%0.8%+26.2%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.
EvidInvest Pro: unlimited filings data, $50/month